Biopharma and Life Science companies in the BioHealth Capital Region are known for their work with cutting edge technologies such as gene and cell therapies. Those strengths were on display at the 6th annual BioHealth Capital Region Forum.
The COVID-19 Pandemic didn’t stop the Maryland Tech Council from holding their 32nd Annual Industry awards. Taking this event online, MTC continued via a live virtual broadcast to recognize the top Life Sciences and Tech Companies in Maryland.
The Bacteriophage (Phage) Therapy (PT) market is growing rapidly in the U.S. The rise of antibiotic resistant bacteria and multidrug-resistant bacteria (MDRs) across the globe has increased the value and industry acceptance of a phage approach, which can help combat bacteria that cannot be effectively treated by antibiotics. What’s more, the phage modality is a great fit for targeted personalized medicine approaches.
Whether it’s “Mom and Pop” retail storefronts, family-run home services companies or life science companies developing innovative, life saving products, family owned-and-operated businesses are the lifeblood of the global economy.
Maryland is the epicenter of biotech and life science innovation in the BioHealth Capital Region (BHCR). The state is home to a burgeoning life science ecosystem, including a rapidly growing cell and gene therapy industry, a robust and growing advanced biomanufacturing environment, and a deep network of leading research universities and critical government life science research entities.
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
The Top BioHealth Capital Region CEOs to Follow on Social Media The BioHealth Capital Region (BHCR) is evolving quickly and it can be tough to keep pace with the latest [….]
The DNA of a Life Science Entrepreneur What Nobel Laureate Dr. Jim Allison’s Story Can Teach Entrepreneurs and Innovators Jim Allison shared the Nobel Prize in Physiology or Medicine in [….]
So, You Want to Join a Life Science Startup?
NASDAQ #TradeTalks Interview with Adaptive Phage Therapeutics CEO: Fighting Antibiotic Resistance with Phage Therapy
Adaptive Phage Therapeutics NASDAQ #TradeTalks